Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Diamedica Therapeutics Inc (NQ: DMAC)
6.920   +0.170 (+2.52%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jul 8, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 106,000
Open 7.280
Bid (Size) 6.850 (4)
Ask (Size) 7.490 (1)
Prev. Close 6.750
Today's Range 6.915 - 7.280
52wk Range 1.700 - 8.800
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+42.39%
+42.39%
1 Month
+47.86%
+47.86%
3 Month
+134.58%
+134.58%
6 Month
+54.81%
+54.81%
1 Year
+54.12%
+54.12%
Top News
More News
DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that it will be participating in the 17th Annual Craig-Hallum Institutional Investor Conference being held virtually on Wednesday, May 27,... Read More
from Business Wire News Releases
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for neurological disorders and chronic kidney disease, announced today that DM199, a... Read More
from Business Wire News Releases
More News
Read More
Why DiaMedica's Stock Is Trading Higher Today
category Analyst Ratings , DMAC , Price Target , and 4 more.
from Benzinga
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
from Business Wire News Releases
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
from Business Wire News Releases
DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
from Business Wire News Releases
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
from Business Wire News Releases
DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020
from Business Wire News Releases
DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020
from Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For July 8, 2020
category GS , Benzinga , BAH , and 36 more.
from Benzinga
75 Biggest Movers From Friday
category PBT , RPTX , RYAM , and 84 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.